Výsledky vyhľadávania - "Henning Andersen"

Consistent improvement with eculizumab across muscle groups in myasthenia gravis.

Autori: Mantegazza, Renato O'Brien, Fanny L. Yountz, Marcus a ďalší

Zdroj: Annals of Clinical & Translational Neurology; Aug2020, Vol. 7 Issue 8, p1327-1339, 13p

Predmety: MYASTHENIA gravis, RESPIRATORY muscles, COMPLEMENT inhibition, MUSCLE strength, ACTIVITIES of daily living, MUSCLES

'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.

Autori: Vissing, John Jacob, Saiju Fujita, Kenji P. a ďalší

Zdroj: Journal of Neurology; Jul2020, Vol. 267 Issue 7, p1991-2001, 11p, 1 Diagram, 2 Charts, 1 Graph

Predmety: THYMECTOMY, MYASTHENIA gravis, CHOLINERGIC receptors, ECULIZUMAB

Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.

Autori: Muppidi, Srikanth Utsugisawa, Kimiaki Benatar, Michael a ďalší

Zdroj: Muscle & Nerve; Jul2019, Vol. 60 Issue 1, p14-24, 11p

Predmety: HEART disease epidemiology, THERAPEUTIC use of monoclonal antibodies, ANGIONEUROTIC edema, ASPERGILLOSIS, HEART diseases, IMMUNOSUPPRESSIVE agents, LONGITUDINAL method, MUSCLE strength, MYASTHENIA gravis, NEISSERIA meningitidis, QUALITY of life, RESEARCH funding, ACTIVITIES of daily living, TREATMENT effectiveness, DISEASE progression, MENINGOCOCCAL vaccines

Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease.

Autori: Kishnani, Priya S. Byrne, Barry J. Claeys, Kristl G. a ďalší

Zdroj: Journal of Patient-Reported Outcomes; 11/13/2024, Vol. 8 Issue 1, p1-9, 9p

Predmety: COMBINATION drug therapy, THERAPEUTICS, RESEARCH funding, INBORN errors of carbohydrate metabolism, ENZYME inhibitors, STATISTICAL sampling, FISHER exact test, FATIGUE (Physiology), QUESTIONNAIRES, RANDOMIZED controlled trials, CHI-squared test, DESCRIPTIVE statistics, FUNCTIONAL status, ANXIETY, ANALYSIS of covariance, QUALITY of life, HEALTH outcome assessment, GLYCOSIDASES, EVALUATION

104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07).

Autori: Schoser, Benedikt Kishnani, Priya S. Bratkovic, Drago a ďalší

Zdroj: Journal of Neurology; May2024, Vol. 271 Issue 5, p2810-2823, 14p

Predmety: GLYCOGEN storage disease type II, ENZYME replacement therapy

Revisiting the Steinberg representation at arbitrary roots of 1.

Autori: Negron, Cris

Zdroj: Representation Theory; 7/16/2025, Vol. 29, p394-442, 49p

Predmety: QUANTUM groups, REPRESENTATION theory, SEMISIMPLE Lie groups, MATHEMATICAL category theory, PROJECTIVE modules (Algebra)

Multiorgan Involvement and Mortality in Individuals With Adult‐Onset Myotonic Dystrophy (DM1)—A Danish Register‐Based Study I.

Autori: Werlauff, Ulla Rudolfsen, Jan Håkon Andersen, Henning a ďalší

Zdroj: European Journal of Neurology; Apr2025, Vol. 32 Issue 4, p1-10, 10p

Predmety: MORTALITY, COMORBIDITY, MYOTONIA atrophica, PSYCHOLOGICAL factors, MEDICAL personnel, ADULTS

Prolegomena to the analysis of deśī words in Hemacandra's Deśīnāmamālā.

Autori: Drocco, Andrea

Zdroj: Kervan: International Journal of Afro-Asiatic Studies; 2024, Vol. 28 Issue 2, p311-355, 45p

Predmety: LEXICON, LEXICOGRAPHY, HETEROGENEITY, SCHOLARS, VOCABULARY

Neuromuscular transmission deficits in patients with CMT and ClC‐1 inhibition in CMT animal models.

Autori: Grønnebæk, Thomas Skjærlund Haahr‐Lillevang, Helga Skov, Martin a ďalší

Zdroj: Annals of Clinical & Translational Neurology; Feb2025, Vol. 12 Issue 2, p320-331, 12p

Predmety: CHLORIDE channels, NEUROMUSCULAR transmission, MYONEURAL junction, MUSCLE fatigue, MUSCLE weakness

Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis.

Autori: Andersen, Henning Mantegazza, Renato Wang, Jing Jing a ďalší

Zdroj: Quality of Life Research; Aug2019, Vol. 28 Issue 8, p2255-2255, 1p

Predmety: MYASTHENIA gravis, ECULIZUMAB, WEB portals, FATIGUE (Physiology)

Mortality in Myasthenia Gravis in Denmark From 1985 to 2020: A Population-Based Cohort Study.

Autori: Jul Jarbæk Nielsen, Josefine Levison, Lotte Andersen, Henning

Zdroj: Neurology; 6/24/2025, Vol. 104 Issue 2, p1-5, 5p

Societal Costs, Healthcare Utilisation and Labour Market Affiliation of Persons With Adult‐Onset Myotonic Dystrophy Type 1 (DM1)—A Register‐Based Study II.

Autori: Handberg, Charlotte Rudolfsen, Jan Håkon Andersen, Henning a ďalší

Zdroj: European Journal of Neurology; Jun2025, Vol. 32 Issue 6, p1-11, 11p

Predmety: MEDICAL care use, LABOR market, EXTERNALITIES, MYOTONIA atrophica, BIOPSYCHOSOCIAL model, DISABILITY retirement

Geografický termín: DENMARK

Tomaš Klir, Vit Boček, Nicolas Jansens, eds. New Perspectives on the Early Slavs and the Rise of Slavic. Contact and Migrations.

Autori: Paliga, Sorin

Zdroj: Hiperboreea; Sep2025, Vol. 12 Issue 1, p84-86, 3p

Predmety: GEOGRAPHIC names, SLAVIC languages, NINETEENTH century, ARCHAEOLOGISTS, INFORMATION resources

Threshold tracking transcranial magnetic stimulation and neurofilament light chain as diagnostic aids in ALS.

Autori: Jacobsen, Anna B. Bostock, Hugh Howells, James a ďalší

Zdroj: Annals of Clinical & Translational Neurology; Jul2024, Vol. 11 Issue 7, p1887-1896, 10p

Predmety: TRANSCRANIAL magnetic stimulation, AMYOTROPHIC lateral sclerosis, CYTOPLASMIC filaments, CEREBROSPINAL fluid, MOTOR neurons

Korporácia: MEDICAL Research Council (Great Britain)

Long-term safety of cyclical rozanolixizumab in patients with generalized myasthenia gravis: Results from the Phase 3 MycarinG study and an open-label extension.

Autori: Habib, Ali A Drużdż, Artur Grosskreutz, Julian a ďalší

Zdroj: Journal of Neuromuscular Diseases; Mar2025, Vol. 12 Issue 2, p231-243, 13p

Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions.

Autori: Bril, Vera Drużdż, Artur Grosskreutz, Julian a ďalší

Zdroj: Journal of Neuromuscular Diseases; Mar2025, Vol. 12 Issue 2, p218-230, 13p

Long‐term safety and tolerability of hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE‐CIDP 3 trial.

Autori: Hadden, Robert D. M. Andersen, Henning Bril, Vera a ďalší

Zdroj: Journal of the Peripheral Nervous System; Dec2024, Vol. 29 Issue 4, p441-452, 12p

Predmety: IMMUNOGLOBULIN analysis, PATIENT safety, DRUG side effects, RESEARCH funding, IMMUNOGLOBULINS, TERMINATION of treatment, EXANTHEMA, GUILLAIN-Barre syndrome, RANDOMIZED controlled trials, DESCRIPTIVE statistics, INJECTIONS, STRUCTURED treatment interruption, ITCHING, VOLUMETRIC analysis, DRUG efficacy, PAIN, DISEASE relapse, DRUG tolerance, GLYCOSIDASES, PATIENT aftercare, EVALUATION, DISEASE risk factors

Early enteral nutrition within 24h of colorectal surgery versus later commencement of feeding for postoperative complications

Autori: Henning Andersen Stephen Lewis Stephen J. Thomas

Zdroj: Cochrane Database of Systematic Reviews.

Predmety: 03 medical and health sciences, Enteral Nutrition, Postoperative Complications, Time Factors, 0302 clinical medicine, Colon, Rectum, Humans, Randomized Controlled Trials as Topic, 3. Good health

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/17054196
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004080.pub2/related-content
https://pubmed.ncbi.nlm.nih.gov/17054196/
https://europepmc.org/article/MED/17054196
http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD004080.pub2/full
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004080.pub2/abstract
https://www.ncbi.nlm.nih.gov/pubmed/17054196

Sonic Heritage of Medieval Bells from the Valdres Region of Norway.

Autori: Đorđević, Zorana Alvarez-Morales, Lidia Novković, Dragan

Zdroj: Heritage (2571-9408); Sep2025, Vol. 8 Issue 9, p359, 21p

Predmety: ACOUSTIC measurements, CHRISTIANITY & culture, SOUND design, CONSERVATION & restoration, CULTURAL property

Geografický termín: NORWAY

Reply to "Post‐COVID myopathy".

Autori: Hejbøl, Eva K. Harbo, Thomas Agergaard, Jane a ďalší

Zdroj: European Journal of Neurology; Dec2022, Vol. 29 Issue 12, p3752-3753, 2p

Predmety: MYASTHENIA gravis, COVID-19, MUSCLE diseases, POST-acute COVID-19 syndrome